Robert Hodgson

York, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Economic Evaluation of Thymectomy for the Treatment of Nonthymomatous Myasthenia Gravis.

Economic Evaluation of Thymectomy for the Treatment of Nonthymomatous Myasthenia Gravis.

Journal: JAMA network open

Published: April 13, 2026

Enzyme replacement therapy compared with best supportive care for the treatment of Pompe Disease: a systematic review and network meta-analysis.

Enzyme replacement therapy compared with best supportive care for the treatment of Pompe Disease: a systematic review and network meta-analysis.

Journal: Health technology assessment (Winchester, England)

Published: February 16, 2026

Artificial Intelligence technologies for assessing skin lesions for referral on the urgent suspected cancer pathway to detect benign lesions and reduce secondary care specialist appointments: early value assessment.

Artificial Intelligence technologies for assessing skin lesions for referral on the urgent suspected cancer pathway to detect benign lesions and reduce secondary care specialist appointments: early value assessment.

Journal: Health technology assessment (Winchester, England)

Published: February 09, 2026

Schrodinger's Pricing: Conceptual and Practical Challenges of Conditional PAS in the NICE Technology Appraisal of Lorlatinib for Untreated ALK-Positive Advanced Non-small-cell Lung Cancer (Review of TA1103): An External Assessment Group Perspective.

Schrodinger's Pricing: Conceptual and Practical Challenges of Conditional PAS in the NICE Technology Appraisal of Lorlatinib for Untreated ALK-Positive Advanced Non-small-cell Lung Cancer (Review of TA1103): An External Assessment Group Perspective.

Journal: PharmacoEconomics

Published: December 23, 2025

Re-anchoring the Value of Innovative Therapies in NICE Decision Making When Comparators are Cost Ineffective: A Case Study of Late-Onset Pompe Disease.

Re-anchoring the Value of Innovative Therapies in NICE Decision Making When Comparators are Cost Ineffective: A Case Study of Late-Onset Pompe Disease.

Journal: PharmacoEconomics

Published: July 30, 2025

Association of quality of life with mortality in patients with adenoid cystic carcinoma using an internationally-validated QoL questionnaire (EQ-5D-5L).

Association of quality of life with mortality in patients with adenoid cystic carcinoma using an internationally-validated QoL questionnaire (EQ-5D-5L).

Journal: Oral oncology

Published: May 01, 2025

Enzyme replacement therapy for the treatment of late onset Pompe disease: A systematic review and network meta-analysis.

Enzyme replacement therapy for the treatment of late onset Pompe disease: A systematic review and network meta-analysis.

Journal: Orphanet journal of rare diseases

Published: March 29, 2025

The cost-effectiveness of enzyme replacement therapies versus best supportive care for treating late onset Pompe disease in the UK NHS.

The cost-effectiveness of enzyme replacement therapies versus best supportive care for treating late onset Pompe disease in the UK NHS.

Journal: The European journal of health economics : HEPAC : health economics in prevention and care

Published: March 29, 2025

A systematic review of the cost-effectiveness of anti-VEGF drugs for the treatment of diabetic retinopathy.

A systematic review of the cost-effectiveness of anti-VEGF drugs for the treatment of diabetic retinopathy.

Journal: Health technology assessment (Winchester, England)

Published: January 30, 2025

Application of Multi-level Network Meta-Regression in the NICE Technology Appraisal of Quizartinib for Induction, Consolidation and Maintenance Treatment of Newly Diagnosed FLT3-ITD-Positive Acute Myeloid Leukaemia: An External Assessment Group Perspective.

Application of Multi-level Network Meta-Regression in the NICE Technology Appraisal of Quizartinib for Induction, Consolidation and Maintenance Treatment of Newly Diagnosed FLT3-ITD-Positive Acute Myeloid Leukaemia: An External Assessment Group Perspective.

Journal: PharmacoEconomics

Published: November 21, 2024

Initial assessment and management of adults with suspected acute respiratory infection: a rapid evidence synthesis of reviews and cost-effectiveness studies.

Initial assessment and management of adults with suspected acute respiratory infection: a rapid evidence synthesis of reviews and cost-effectiveness studies.

Journal: Health technology assessment (Winchester, England)

Published: September 13, 2024

Devices for remote continuous monitoring of people with Parkinson's disease: a systematic review and cost-effectiveness analysis.

Devices for remote continuous monitoring of people with Parkinson's disease: a systematic review and cost-effectiveness analysis.

Journal: Health technology assessment (Winchester, England)

Published: July 18, 2024

Showing 1-12 of 41

Last Updated: 09/26/2026